# Ketamine + Mindfulness for Depression

> **NCT05168735** · PHASE1,PHASE2 · COMPLETED · sponsor: **Rebecca Price** · enrollment: 43 (actual)

## Conditions studied

- Depression, Unipolar

## Interventions

- **DRUG:** Intravenous Ketamine
- **BEHAVIORAL:** Brief Mindfulness Exercises
- **BEHAVIORAL:** Academic Exercises

## Key facts

- **NCT ID:** NCT05168735
- **Lead sponsor:** Rebecca Price
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05168735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05168735, "Ketamine + Mindfulness for Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05168735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*